KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) EBT (2017 - 2025)

Guardant Health's EBT history spans 9 years, with the latest figure at -$130.2 million for Q4 2025.

  • For Q4 2025, EBT fell 18.07% year-over-year to -$130.2 million; the TTM value through Dec 2025 reached -$417.5 million, up 4.03%, while the annual FY2025 figure was -$417.5 million, 4.03% up from the prior year.
  • EBT for Q4 2025 was -$130.2 million at Guardant Health, down from -$92.6 million in the prior quarter.
  • Across five years, EBT topped out at -$72.3 million in Q2 2023 and bottomed at -$229.0 million in Q2 2022.
  • The 5-year median for EBT is -$107.6 million (2021), against an average of -$118.5 million.
  • The largest annual shift saw EBT crashed 237.1% in 2021 before it surged 68.44% in 2023.
  • A 5-year view of EBT shows it stood at -$72.3 million in 2021, then tumbled by 92.71% to -$139.3 million in 2022, then crashed by 34.63% to -$187.6 million in 2023, then surged by 41.21% to -$110.3 million in 2024, then fell by 18.07% to -$130.2 million in 2025.
  • Per Business Quant, the three most recent readings for GH's EBT are -$130.2 million (Q4 2025), -$92.6 million (Q3 2025), and -$99.9 million (Q2 2025).